Sign in >>

News item: 12.02.2010 - DJ DGAP-Adhoc: Sanochemia Pharmazeutika AG: Successful clinical PVP hypericin Phase II study (4investors)

Dissemination of an Ad hoc announcement according to ยง 15 WpHG, transmitted by DGAP – a company of EquityStory AG. The issuer is solely responsible for the content of this announcement.

Posted almost 2 years ago

Continue reading...

Back to news index

Related sites from Google



Send feedback about this page
Email a link to this page

This topic elsewhere

Loading...
Loading...